We found that the GE independent shared targets, the majority of which have higher binding to MSI2 in LSCs versus LSKs, are enriched for both normal HSPC-related as well as MLL-AF9 leukemia programs (Fig. 3j). The gene discussed is KMT2A; the disease is leukemia.